Lineage Sale Purchase Of Stock from 2010 to 2025

LCTX Stock  USD 0.50  0.02  3.85%   
Lineage Cell Sale Purchase Of Stock yearly trend continues to be fairly stable with very little volatility. Sale Purchase Of Stock is likely to outpace its year average in 2025. During the period from 2010 to 2025, Lineage Cell Sale Purchase Of Stock regression line of annual values had r-squared of  0.37 and arithmetic mean of  15,560,485. View All Fundamentals
 
Sale Purchase Of Stock  
First Reported
1992-06-30
Previous Quarter
23 K
Current Value
0.0
Quarterly Volatility
5.8 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lineage Cell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lineage Cell's main balance sheet or income statement drivers, such as Depreciation And Amortization of 922.5 K, Interest Expense of 6 M or Total Revenue of 10 M, as well as many indicators such as Price To Sales Ratio of 10.06, Dividend Yield of 0.0015 or PTB Ratio of 1.37. Lineage financial statements analysis is a perfect complement when working with Lineage Cell Valuation or Volatility modules.
  
Check out the analysis of Lineage Cell Correlation against competitors.

Latest Lineage Cell's Sale Purchase Of Stock Growth Pattern

Below is the plot of the Sale Purchase Of Stock of Lineage Cell Therapeutics over the last few years. It is Lineage Cell's Sale Purchase Of Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lineage Cell's overall financial position and show how it may be relating to other accounts over time.
Sale Purchase Of Stock10 Years Trend
Slightly volatile
   Sale Purchase Of Stock   
       Timeline  

Lineage Sale Purchase Of Stock Regression Statistics

Arithmetic Mean15,560,485
Geometric Mean832,968
Coefficient Of Variation142.89
Mean Deviation19,765,462
Median(21,850)
Standard Deviation22,234,495
Sample Variance494.4T
Range64.6M
R-Value(0.61)
Mean Square Error333.1T
R-Squared0.37
Significance0.01
Slope(2,845,269)
Total Sum of Squares7415.6T

Lineage Sale Purchase Of Stock History

2025-21.9 K
2024-23 K
2023-37 K
2022-17 K
2021-54 K
2020-27 K
2019-110 K

About Lineage Cell Financial Statements

Lineage Cell investors use historical fundamental indicators, such as Lineage Cell's Sale Purchase Of Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lineage Cell. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Sale Purchase Of Stock-23 K-21.9 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lineage Stock Analysis

When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.